Hotland Biotech: plans to sell no more than 1,854,200 repurchased shares within the next 6 months.

Hot Springs Biology announced that the company repurchased a total of 2.893 million shares from February 8 to May 7, 2024, which had not been sold as of the disclosure date of the announcement. On December 23, 2025, the board of directors of the company agreed to sell a maximum of 1.8542 million repurchased shares through centralized bidding within 6 months after the disclosure of the announcement, representing approximately 2% of the total share capital. The funds raised will be used to supplement the working capital. The controlling shareholder, Lin Changqing, will reduce his holdings by 1 million shares within 6 months prior to the board resolution.